Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARLS Trial
PACTR202403785563823Phase 3Not yet recruiting
- Sponsor
- Concept Foundation
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Phase 3 trial of aspirin in preeclampsia (2 arms), sponsored by Concept Foundation. Primary endpoints: Birth before 37 weeks with pre-eclampsia and Composite postpartum hemorrhage-related treatment measure. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on PACTR202403785563823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202403785563823.